Rekah Pharmaceutical Industry Ltd. (REKA.TA)

TLV • Market Data in ILA, Fundamentals in ILS Market ILA / Fundamentals ILS

ILA 1.22K

-ILA 56.00

-4.39%

Last Update: 10 Jul 2025, 14:24

ILA 139.26M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

ILA 1.13K - ILA 1.60K

52 Week Range

REKA.TA Stock Price Chart

Explore Rekah Pharmaceutical Industry Ltd. interactive price chart. Choose custom timeframes to analyze REKA.TA price movements and trends.

There is nothing to show.

REKA.TA Company Profile

Discover essential business fundamentals and corporate details for Rekah Pharmaceutical Industry Ltd. (REKA.TA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

12 Aug 2002

Employees

421.00

Website

https://www.rekah.co.il

CEO

Mordechai Elgrabli

Description

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.

REKA.TA Financial Timeline

Browse a chronological timeline of Rekah Pharmaceutical Industry Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 9 May 2025

EPS came in at -ILA 0.19, while revenue for the quarter reached ILA 76.16M.

Earnings released on 30 Sept 2024

EPS came in at -ILA 0.39, while revenue for the quarter reached ILA 87.19M.

Earnings released on 30 Jun 2024

EPS came in at ILA 1.05, while revenue for the quarter reached ILA 68.69M.

Earnings released on 9 May 2024

EPS came in at -ILA 0.08, while revenue for the quarter reached ILA 86.04M.

Earnings released on 31 Mar 2024

EPS came in at ILA 0.11, while revenue for the quarter reached ILA 89.67M.

Earnings released on 30 Sept 2023

EPS came in at -ILA 0.48, while revenue for the quarter reached ILA 79.96M.

Earnings released on 30 Jun 2023

EPS came in at -ILA 0.10, while revenue for the quarter reached ILA 76.66M.

Earnings released on 31 Mar 2023

EPS came in at ILA 0.05, while revenue for the quarter reached ILA 79.00M.

Earnings released on 31 Dec 2022

EPS came in at -ILA 0.20, while revenue for the quarter reached ILA 79.67M.

Earnings released on 30 Sept 2022

EPS came in at ILA 0.03, while revenue for the quarter reached ILA 73.41M.

Earnings released on 30 Jun 2022

EPS came in at -ILA 0.05, while revenue for the quarter reached ILA 66.85M.

Dividend declared on 6 Apr 2022

A dividend of ILA 86.78 per share was announced, adjusted to ILA 86.78. The dividend was paid on 14 Apr 2022.

Earnings released on 31 Mar 2022

EPS came in at ILA 0.05, while revenue for the quarter reached ILA 72.46M.

Earnings released on 31 Dec 2021

EPS came in at ILA 0.29, while revenue for the quarter reached ILA 74.19M.

Earnings released on 30 Sept 2021

EPS came in at ILA 0.00, while revenue for the quarter reached ILA 61.98M.

Earnings released on 30 Jun 2021

EPS came in at ILA 0.12, while revenue for the quarter reached ILA 63.10M.

Earnings released on 31 Mar 2021

EPS came in at ILA 0.16, while revenue for the quarter reached ILA 64.68M.

Earnings released on 31 Dec 2020

EPS came in at ILA 0.16, while revenue for the quarter reached ILA 72.32M.

Earnings released on 30 Sept 2020

EPS came in at ILA 0.34, while revenue for the quarter reached ILA 72.72M.

REKA.TA Stock Performance

Access detailed REKA.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.